Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

Contraceptives Market by Product [Drugs (oral, injectable and topical) Devices (condoms, IUDs, diaphragms, sponges, patches, implants, vaginal rings)], by Age Group (Age 15-24, Age 25-34, Age 35-44 and Above 44), by Education (Less Than High School, High School Graduate, College Graduate and Other College Degrees) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

LI_16451
Pages: 155
Sep 2016 | 2688 Views
face gplus_n
Author's : Garima Chandra
Tables: 71
Charts: 65
twit_n pr_n

Contraceptives Market - Industry Analysis

The global contraceptives market generated a revenue of $28,175 million in 2015 and is estimated to reach $43,812 million by 2022, registering a CAGR of 6.4% during the analysis period. Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.

The contraception encompasses the use of drugs (oral pills, injectable contraceptives, and topical contraceptives) and devices (condoms, intrauterine device [IUD], diaphragms, sponges, patches, implants, vaginal rings, and others). The growth in focus towards the need of family planning and preventing unintended pregnancy fuels the market growth. In addition, the increase in use of contraception in young women along with the rise in higher educational attainment propels the market growth. Moreover, health issues associated with teenage pregnancies, increase in awareness of modern contraception, and rise in use of oral pills as a key method to avoid unplanned pregnancy further drive the market growth. However, health risks associated with the use of contraceptives, availability of alternate contraceptive methods, and lack of social acceptance might adversely affect the market growth.

Contraceptives Market

The contraceptives industry is segmented on the basis of product, age group, education, end-user, and geography. Contraceptive drugs and devices are two major product categories of the contraceptives market. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives industry is the largest within the contraceptive drug market owing to the widespread use of oral pills by women. This is mainly because they are proven to be highly effective up to 99% in preventing pregnancy. In addition, contraceptive devices are further categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. In terms of revenue, the condoms are the most commonly used contraceptive devices accounting for around two-thirds of the contraceptives market share in 2015. However, IUDs gain momentum and are expected to grow at a faster pace during the analysis period.

Contraceptives Market

Contraceptives Market Analysis by End User:

Contraceptive drugs and devices are employed by a set of end users for pregnancy control, of sexually transmitted infections (STIs), and for birth control & family planning. In this report, the end user comprises of household, clinics, and hospitals.

Contraceptives Market

Household

Households accounted for the largest share in the contraceptive market owing to the widespread consumption of oral pills and condoms to prevent unintended pregnancy and STIs. Contraceptives preferred for use in households include oral pills, topical contraceptives, vagina ring, contraceptive patches, contraceptive diaphragms, and sponges. These contraceptives help to reduce the risk of pregnancy and STIs. The increase in use of contraceptives at home has improved health-related outcomes, such as maternal & infant mortality, reduced risk of STIs, such as HIV, hepatitis B, syphilis, and gonorrhea along with improved economic outcomes of a family.

Hospitals  

Contraceptives offered in hospitals comprise of IUD, injectable contraceptives, sub-dermal contraceptive implants, contraceptive vaginal rings, and others, where IUDs become one of the most preferable choice. Hospitals provide permanent methods such as male and female sterilization. However, IUDs and implants are primarily offered at hospitals to stop birth control. These methods require special training, experienced experts, and service delivery conditions to safely carry out required procedures. 

Clinics 

Clinics hold a significant share in the contraceptive industry as they provide services for all ages and genders that include low cost contraceptives, infection tests, pregnancy tests & diagnosis, non-judgmental birth control counseling, and sexual health information. The clinical methods of family planning were more often available in health centers and dispensaries. Also, clinics offer confidential and free advice along with information regarding better contraceptive method and sexual health. This has specifically contributed for the high growth for clinics in the contraceptive market. 

Now-a-days, clinics provide FDA-approved contraceptive methods, which include oral contraceptives, long-acting reversible contraception (IUD or implant), injectable (Depo-Provera), other hormonal methods (patch or ring), male barrier (condom), female barrier (diaphragm or cervical cap or sponge or female condom or spermicides), and emergency contraception. 

The North American region comprises three countries in the reportU.S., Canada, and Mexico. North America has experienced a minimal change in the contraceptive methods usage rates and the usage has been decreased by 0.3%; however, the region has the highest contraceptive prevalence74.8%. Effective contraceptive methods such as pills, male condom, IUD, injectable, implant, and other modern barrier methods dominate the North American region. According to Guttmacher Institute, the percentage of women in the country using long-acting reversible contraceptives (for instance, IUDs and hormonal implants) has increased from 9% in 2009 to about 12% in 2012. 

The combined hormonal contraceptives segment dominates the overall drugs segment in North America, which lead to their high usage in the prevention of pregnancy or birth control. According to the Affordable Care Act, the health insurance companies provide 100% insurance to the users of the contraceptive methods.

The report provides a comprehensive analysis of the key players that operate in the contraceptives market, namely, The Female Health Company, Teva Pharmaceutical Industries Limited, Allergan plc, Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.

Other players in the value chain include Reckitt Benckiser Plc, Warner Chilcott Company, BioSante Pharmaceuticals Inc., Agile Therapeutics Inc., HLL Lifecare Limited, MANKIND Pharmaceuticals, TTK HealthCare, Boehringer Ingelheim GmbH, Watson Pharmaceuticals, Inc., V-Care Pharma Pvt. Ltd., Vardhman Life care pvt. Ltd., and Cipla Limited. 

CONTRACEPTIVES MARKET KEY BENEFITS

  • The study provides an in-depth analysis of the entire contraceptives market size with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product (both contraceptive drugs and devices) interprets the need to prevent unintended pregnancy and STIs. 
  • The report provides information regarding key drivers, restraints, and opportunities with a detailed impact analysis.
  • Porter’s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.

CONTRACEPTIVES MARKET KEY SEGMENTS

BY PRODUCT

  • Drugs
    • Oral Contraceptive Pills
    • Injectable Contraceptives
    • Topical Contraceptives
  • Devices
    • Condoms
    • Female Condoms
    • Male Condoms
  • Intrauterine Devices (IUDs)
  • Hormonal IUDs
  • Copper IUDs
  • Diaphragms
  • Sponges
  • Patches
  • Implants
  • Vaginal Rings
  • Others

AGE GROUP

  • 15‐24 years
  • 25‐34 years
  • 35‐44 years
  • Above 44 years

BY EDUCATION

  • Less than high school
  • High school graduate
  • College graduate
  • Other college degrees

BY END USER

  • Household
  • Hospitals
  • Clinics

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • UAE
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porter’s five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitutes
3.3.5 High intensity of rivalry

3.4 Regulatory scenario

3.4.1 Government regulations across countries
3.4.2 Preventive services guidelines for women
3.4.3 FDA-approved contraceptives method
3.4.4 The Affordable Care Act: contraceptive coverage and advantages

3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Rise in need for preventing unwanted pregnancy
3.5.1.2 Increasing awareness for contraceptives worldwide
3.5.1.3 Rising usage of oral contraceptives as a preferred method to avoid unplanned pregnancy
3.5.1.4 Technological advancements in contraceptive methods
3.5.1.5 Upsurge in government and NGO initiatives promoting contraceptives
3.5.1.6 Increasing awareness about STDs

3.5.2 Restraints

3.5.2.1 Health risks associated with the use of contraceptive methods
3.5.2.2 Lack of social acceptance

3.5.3 Opportunities

3.5.3.1 Rise in disposable income and demand for healthy life in emerging economies
3.5.3.2 Presence of large unmet contraceptive needs in emerging Asian and African Economies

Chapter: 4 WORLD CONTRACEPTIVES MARKET, BY PRODUCT, 2014–2022

4.1 Overview

4.1.1 Market size and forecast

4.2 Drugs

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Oral contraceptive or pills

4.2.4.1 Market size and forecast

4.2.5 Injectable contraceptives

4.2.5.1 Market size and forecast

4.2.6 Topical contraceptives

4.2.6.1 Market size and forecast

4.3 Contraceptive devices

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Condoms

4.3.4.1 Market size and forecast
4.3.4.2 Female condoms

4.3.4.2.1 MARKET SIZE AND FORECAST

4.3.4.3 Male condoms

4.3.4.3.1 MARKET SIZE AND FORECAST

4.3.5 Intrauterine devices (IUDs)

4.3.5.1 Market size and forecast
4.3.5.2 Hormonal IUDs

4.3.5.2.1 MARKET SIZE AND FORECAST

4.3.5.3 Copper IUDs

4.3.5.3.1 MARKET SIZE AND FORECAST

4.3.6 Contraceptive diaphragms

4.3.6.1 Market size and forecast

4.3.7 Contraceptive sponges

4.3.7.1 Market size and forecast

4.3.8 Contraceptive patches

4.3.8.1 Market size and forecast

4.3.9 Subdermal contraceptive implants

4.3.9.1 Market size and forecast

4.3.10 Contraceptive vaginal rings

4.3.10.1 Market size and forecast

4.3.11 Others

4.3.11.1 Market size and forecast

Chapter: 5 WORLD CONTRACEPTIVES MARKET, BY AGE GROUP

5.1 Overview

5.1.1 Market size and forecast

5.2 15-24 years

5.2.1 Market size and forecast

5.3 25–34 years

5.3.1 Market size and forecast

5.4 35–44 years

5.4.1 Market size and forecast

5.5 Above 44 years

5.5.1 Market size and forecast

Chapter: 6 WORLD CONTRACEPTIVES MARKET, BY EDUCATION

6.1 Overview

6.1.1 Market size and forecast

6.2 Less than high school

6.2.1 Market size and forecast

6.3 High school graduate

6.3.1 Market size and forecast

6.4 College graduate

6.4.1 Market size and forecast

6.5 Other college degrees

6.5.1 Market size and forecast

Chapter: 7 WORLD CONTRACEPTIVES MARKET, BY END USER

7.1 Overview

7.1.1 Market size and forecast

7.2 Household

7.2.1 Market size and forecast

7.3 Hospitals

7.3.1 Market size and forecast

7.4 Clinics

7.4.1 Market size and forecast

Chapter: 8 WORLD CONTRACEPTIVES MARKET, BY GEOGRAPHY, 2014–2022

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast

8.2.3.1 U.S. contraceptives market
8.2.3.2 Canada contraceptives market
8.2.3.3 Mexico contraceptives market

8.3 Europe

8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast

8.3.3.1 Germany contraceptives market
8.3.3.2 France contraceptives market
8.3.3.3 UK contraceptives market
8.3.3.4 Rest of Europe contraceptives market

8.4 Asia-Pacific

8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast

8.4.3.1 Japan contraceptives market
8.4.3.2 China contraceptives market
8.4.3.3 Australia contraceptives market
8.4.3.4 India contraceptives market
8.4.3.5 Rest of Asia-Pacific contraceptives market

8.5 LAMEA

8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast

8.5.3.1 Brazil contraceptives market
8.5.3.2 Turkey contraceptives market
8.5.3.3 Venezuela contraceptives market
8.5.3.4 South Africa contraceptives market
8.5.3.5 Saudi Arabia contraceptives market
8.5.3.6 Rest of LAMEA contraceptives market

Chapter: 9 COMPANY PROFILES

9.1 Mylan N.V.

9.1.1 Company overview
9.1.2 Operating business segments
9.1.3 Business performance
9.1.4 Key strategic moves & developments

9.2 Ansell Limited

9.2.1 Company overview
9.2.2 Operating business segments
9.2.3 Business performance
9.2.4 Key strategic moves & developments

9.3 Bayer AG

9.3.1 Company overview
9.3.2 Operating business segments
9.3.3 Business performance
9.3.4 Key strategic moves & developments

9.4 Church & Dwight Co., Inc.

9.4.1 Company overview
9.4.2 Operating business segments
9.4.3 Business performance

9.5 Merck & Co., Inc.

9.5.1 Company overview
9.5.2 Operating business segments
9.5.3 Business performance

9.6 Pfizer Inc.

9.6.1 Company overview
9.6.2 Operating business segments
9.6.3 Business performance
9.6.4 Key strategic moves & developments

9.7 Teva Pharmaceutical Industries Limited

9.7.1 Company overview
9.7.2 Operating business segments
9.7.3 Business performance
9.7.4 Key strategic moves & developments

9.8 The Cooper Companies, Inc.

9.8.1 Company overview
9.8.2 Operating business segments
9.8.3 Business performance
9.8.4 Key strategic moves & developments

9.9 The Female Health Company

9.9.1 Company overview
9.9.2 Operating business segments
9.9.3 Business performance
9.9.4 Key strategic moves & developments

9.10 Mayer Laboratories, Inc.

9.10.1 Company overview

List of Figures

FIG. 1 MARKET SEGMENTATION FOR CONTRACEPTIVES MARKET
FIG. 2 TOP INVESTMENT POCKETS
FIG. 3 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20142016)
FIG. 4 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 5 PORTERS FIVE FORCES ANALYSIS
FIG. 6 PRIVATELY INSURED WOMEN PERCENTAGE WHO PAID $0 FOR THE CONTRACEPTIVE METHOD
FIG. 7 TOP IMPACTING FACTORS
FIG. 8 PERCENTAGE OF PREGNANCY BY INTENTION
FIG. 9 WORLD CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2015 (%)
FIG. 10 WORLD ORAL CONTRACEPTIVES OR PILLS MARKET, 2014 - 2022 ($MILLION)
FIG. 11 WORLD CONTRACEPTIVES INJECTABLES MARKET, 2014 - 2022 ($MILLION)
FIG. 12 WORLD TOPICAL CONTRACEPTIVES MARKET, 2014 - 2022 ($MILLION)
FIG. 13 WORLD CONTRACEPTIVE DIAPHRAGM MARKET, 2014 - 2022 ($MILLION)
FIG. 14 WORLD CONTRACEPTIVE SPONGE MARKET, 2014 - 2022 ($MILLION)
FIG. 15 WORLD CONTRACEPTIVE PATCH MARKET, 2014 - 2022 ($MILLION)
FIG. 16 WORLD SUB-DERMAL CONTRACEPTIVE IMPLANTS MARKET, 2014 - 2022 ($MILLION)
FIG. 17 WORLD VAGINAL RINGS MARKET, 2014 - 2022 ($MILLION)
FIG. 18 WORLD OTHER CONTRACEPTIVE DEVICES MARKET, 2014 - 2022 ($MILLION)
FIG. 19 WORLD CONTRACEPTIVES MARKET FOR 15-24 YEARS, 2014 - 2022 ($MILLION)
FIG. 20 WORLD CONTRACEPTIVES MARKET FOR 25-34 YEARS, 2014 - 2022 ($MILLION)
FIG. 21 WORLD CONTRACEPTIVES MARKET FOR 35-44 YEARS, 2014 - 2022 ($MILLION)
FIG. 22 WORLD CONTRACEPTIVES MARKET FOR ABOVE 44 YEARS, 2014 - 2022 ($MILLION)
FIG. 23 WORLD CONTRACEPTIVES MARKET FOR LESS THAN HIGH SCHOOL, 2014 - 2022 ($MILLION)
FIG. 24 WORLD CONTRACEPTIVES MARKET FOR HIGH SCHOOL GRADUATE, 2014 - 2022 ($MILLION)
FIG. 25 WORLD CONTRACEPTIVES MARKET FOR COLLEGE GRADUATE, 2014 - 2022 ($MILLION)
FIG. 26 WORLD CONTRACEPTIVES MARKET FOR OTHER COLLEGE DEGREES, 2014 - 2022 ($MILLION)
FIG. 27 WORLD CONTRACEPTIVES MARKET, BY END USER, 2015 (%)
FIG. 28 CONTRACEPTIVES MARKET FOR HOUSEHOLD, BY REGION, 2014 - 2022 (%)
FIG. 29 CONTRACEPTIVES MARKET FOR HOSPITAL, BY REGION, 2014 - 2022 (%)
FIG. 30 CONTRACEPTIVES MARKET FOR CLINICS, BY REGION, 2014 - 2022 (%)
FIG. 31 MORE EFFECTIVE CONTRACEPTIVES USE, BY COUNTRY
FIG. 32 WORLD CONTRACEPTIVES MARKET, BY REGION, 2015 (%)
FIG. 33 NORTH AMERICA CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 34 U.K.: CONTRACEPTION USE BY WOMEN, BY AGE, 20082009
FIG. 35 EUROPE CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 36 ASIA PACIFIC CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 37 LAMEA CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 38 ALLERGAN: NET SALES, 20132015 ($MILLION)
FIG. 39 ALLERGAN: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 40 ALLERGAN: STRATEGY SHARE, 20142016 (%)
FIG. 41 ANSELL LIMITED: NET SALES, 20132015 ($MILLION)
FIG. 42 ANSELL LIMITED: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 43 ANSELL LIMITED: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 44 ANSELL LIMITED: STRATEGY SHARE, 20152016 (%)
FIG. 45 BAYER: NET SALES, 20132015 ($MILLION)
FIG. 46 BAYER: NET SALES, BY SEGMENTS, 2015 (%)
FIG. 47 BAYER: NET SALES, BY GEOGRAPHY, 2015(%)
FIG. 48 CHURCH & DWIGHT: NET SALES, 20132015 ($MILLION)
FIG. 49 CHURCH & DWIGHT: NET SALES, BY SEGMENT, 2015, (%)
FIG. 50 MERCK: NET SALES, 20132015 ($MILLION)
FIG. 51 MERCK: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 52 MERCK: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 53 PFIZER: NET SALES, 20132015 ($MILLION)
FIG. 54 PFIZER: NET SALES, BY SEGMENT, 2015 (%)
FIG. 55 PFIZER: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 56 PFIZER: STRATEGY SHARE, (%)
FIG. 57 TEVA PHARMACEUTICAL: NET SALES, 20132015 ($MILLION)
FIG. 58 TEVA PHARMACEUTICAL: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 59 TEVA PHARMACEUTICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 60 COOPER: NET SALES, 20132015 ($MILLION)
FIG. 61 COOPER: NET SALES, BY BUSINESS SEGMENT, 2015 ($MILLION)
FIG. 62 COOPER: NET SALES, BY GEOGRAPHY, 2015, (%)
FIG. 63 FHC: NET SALES, 20132015 ($MILLION)
FIG. 64 FHC: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIG. 65 FHC: STRATEGY SHARE (%), 20142016

List of Tables

TABLE 1 WORLD CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 2 WORLD CONTRACEPTIVES MARKET, BY DRUG TYPE, 20142022 ($MILLION)
TABLE 3 WORLD CONTRACEPTIVES MARKET, BY DEVICE TYPE, 20142022 ($MILLION)
TABLE 4 WORLD CONDOM MARKET, BY TYPE, 2014 - 2022 ($MILLION)
TABLE 5 WORLD FEMALE CONDOMS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 6 WORLD MALE CONDOMS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 7 WORLD INTRAUTERINE DEVICES (IUD) MARKET, BY TYPE 2014 2022 ($MILLION)
TABLE 8 WORLD HORMONAL IUDS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 9 WORLD COPPER IUDS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 10 WORLD CONTRACEPTIVES MARKET, BY AGE GROUP, 20142022 ($MILLION)
TABLE 11 WORLD CONTRACEPTIVES MARKET, BY EDUCATION, 20142022 ($MILLION)
TABLE 12 WORLD CONTRACEPTIVES MARKET, BY END USER, 20142022 ($MILLION)
TABLE 13 CONTRACEPTIVES MARKET FOR HOUSEHOLD, BY REGION, 20142022 ($MILLION)
TABLE 14 CONTRACEPTIVES MARKET FOR HOSPITALS, BY REGION, 20142022 ($MILLION)
TABLE 15 CONTRACEPTIVES MARKET FOR CLINICS, BY REGION, 20142022 ($MILLION)
TABLE 16 CONTRACEPTIVES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 NORTH AMERICA: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 18 NORTH AMERICA: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 19 NORTH AMERICA: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 20 NORTH AMERICA: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 21 NORTH AMERICA: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 22 U.S. CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 23 CANADA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 24 MEXICO CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 25 EUROPE: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 26 EUROPE: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 27 EUROPE: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 28 EUROPE: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 29 EUROPE: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 30 GERMANY CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 31 FRANCE CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 32 U.K. CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 33 REST OF EUROPE CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 34 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 35 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 36 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 37 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 38 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 39 JAPAN CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 40 CHINA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 41 AUSTRALIA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 42 INDIA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 43 REST OF ASIA PACIFIC CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 44 LAMEA: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 45 LAMEA: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 46 LAMEA: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 47 LAMEA: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 48 LAMEA: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 49 BRAZIL CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 50 TURKEY CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 51 VENEZUELA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 52 SOUTH AFRICA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 53 REST OF LAMEA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 54 ALLERGAN - COMPANY SNAPSHOT
TABLE 55 ALLERGAN - OPERATING SEGMENTS
TABLE 56 ANSELL LIMITED - COMPANY SNAPSHOT
TABLE 57 ANSELL LIMITED - OPERATING SEGMENTS
TABLE 58 BAYER - COMPANY SNAPSHOT
TABLE 59 BAYER - OPERATING SEGMENTS
TABLE 60 CHURCH & DWIGHT - COMPANY SNAPSHOT
TABLE 61 CHURCH & DWIGHT - OPERATING SEGMENTS
TABLE 62 MERCK - COMPANY SNAPSHOT
TABLE 63 MERCK - PRODUCT CATEGORIES
TABLE 64 PFIZER - COMPANY SNAPSHOT
TABLE 65 PFIZER - OPERATING SEGMENTS
TABLE 66 TEVA PHARMACEUTICAL - COMPANY SNAPSHOT
TABLE 67 TEVA PHARMACEUTICAL - OPERATING SEGMENTS
TABLE 68 COOPER - COMPANY SNAPSHOT
TABLE 69 COOPER: OPERATING SEGMENTS
TABLE 70 FHC - COMPANY SNAPSHOT
TABLE 71 MAYER - COMPANY SNAPSHOT

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Contraceptives Market- Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts